RUA — Rua Bioscience Cashflow Statement
0.000.00%
- NZ$8.05m
- NZ$8.61m
- NZ$1.51m
- 11
- 41
- 50
- 24
Annual cashflow statement for Rua Bioscience, fiscal year end - June 30th, NZD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 0.691 | 0.696 | 0.104 | 0.755 | 0.268 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -4.45 | -6.84 | -5.92 | -3.74 | -2.79 |
| Capital Expenditures | -1.4 | -0.4 | -0.074 | -0.001 | -0.003 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -13 | 5.99 | 6.75 | 2.21 | 0.109 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -14.4 | 5.59 | 6.67 | 2.21 | 0.106 |
| Financing Cash Flow Items | -1.54 | -0.045 | -0.019 | -0.017 | -0.175 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 18.3 | -0.209 | -0.12 | -0.095 | 2.02 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.578 | -1.46 | 0.632 | -1.63 | -0.654 |